Discover the innovative work being done by California Life Science member companies.
Member News
CLS members can submit articles, press releases, whitepapers, and/or blogs to be featured on the ‘Member Voice’ section of our website.
Not yet a member? Join CLS today to start taking advantage of this exclusive member benefit.

Biointron Insights: Antibody Industry Report (Q2 2025 Insights, Trends & Analysis)
By CLS Member: Biointron
07/08/25 – Biointron’s Q2 2025 Antibody Industry Report aims to explore the events and trends of the biopharmaceutical industry in April, May, and June. This quarter, 5 novel monoclonal antibody drugs have been approved by at least one regulatory agency around the world: three from US, one from EU, and one from China. Read more here!

Katalyze AI Launches Digityze AI on Snowflake AI Data Cloud, Enabling GMP-Ready Intelligence for Biomanufacturing
By CLS Member: Katalyze AI
07/08/25 – Available on Snowflake Marketplace, Digityze AI combines advanced machine learning, biophysics-informed models, and visual AI to organize complex manufacturing documents, including PDFs, handwritten notes, tables, forms, and fragmented data, unlocking critical insights. Read more here!

At risk of missing your go-live date? We’ve been there, and we can help.
By CLS Member: Project Outlier
06/27/25 – Our global pharma client needed to integrate data from 80+ local HR systems to their centralized Workday® platform in 12 months—halfway through, the project was wildly off-track. Learn more here!

Breaking Barriers: How Kemwell’s Mitigation Strategy Overcomes Viscosity-Induced High-Concentration TFF Challenges
By CLS Member: Kemwell Biopharma
06/25/25 – Recent advances in biologics development are primarily focused on development of high titre producing cell lines to substantiate the requirement of high dosage mAbs (600-700 mg drug per dose).This also brings in the requirement of subcutaneous injectables to alleviate the hassles of IV infusion. This poster focuses on the strategy to achieve concentration of >200 mg/mL for mAbs. Learn more here!

New England Biolabs®: More Time for Demanding Tasks with SAP BTP Services
By CLS Member: consolut
06/25/25 – New England Biolabs® receives up to 2,000 incoming invoices each month. The majority of these are received as email attachments that employees must review, capture and store. Learn more here!

Exhibitor Opportunity: Medical Fair Thailand
By California Governor’s Office of Business and Economic Development (GO-Biz)
06/20/25 – The California Governor’s Office of Business and Economic Development(GO–Biz) is leading a California Pavilion to exhibit at Medical Fair Thailand in Bangkok from September 9 to September 12, 2025. This trade mission will include a custom-designed turnkey booth for 6 California businesses, in-country consulting and business matchmaking service, two site visits, and other networking opportunities. Learn more here!

Tactical Execution of Commercial Strategy (TECS) in Life Sciences Sales
By CLS Member: Flannery Sales Systems
06/19/25 – In today’s competitive market, a well-defined commercial strategy is essential for achieving long-term success in sales. But what separates high-performing sales teams from those that struggle isn’t just the strategy itself—it’s how effectively that strategy is executed. Read more here!

CHO Plus Selected for 2025 BioTools Innovator Accelerator Program
By CLS Member: CHO Plus
06/18/25 – CHO Plus, a leading developer of biopharmaceutical manufacturing technology, announced its selection for the 2025 BioTools Innovator Accelerator. Read more here!

King Faisal Specialist Hospital & Research Centre and Germfree Laboratories Announce Landmark Advanced Therapy Manufacturing Campus in Riyadh
By CLS Member: Germfree
06/17/25 – King Faisal Specialist Hospital & Research Centre and Germfree Laboratories have partnered to launch a landmark advanced therapy manufacturing campus in Riyadh. This collaboration marks a significant step toward strengthening Saudi Arabia’s biomanufacturing capabilities and advancing the Kingdom’s position in global healthcare innovation. Read more here!

How Confident Are You that Your Organization Has The Right Tech in Place to Scale from IND to Phase 3 Trials?
By CLS Member: Project Outlier
06/12/25 – Despite the uncertainty in Biotech and Pharma, your organization will always need reliable, high-performing technology. Do you have the right systems in place to support end to end clinical trials? To ensure product quality? To enable commercialization? Check out our Clinical Tech Stack Blueprint to start assessing whether your IT landscape is built to scale. Read more here!

Germfree Launches Smarthood: A Groundbreaking, Software-Agnostic IV Workflow Solution Transforming Sterile Compounding
By CLS Member: Germfree
06/05/25 – Germfree is proud to introduce Smarthood, an innovative, software-agnostic IV workflow solution designed to revolutionize sterile compounding environments. Built to integrate seamlessly with any existing pharmacy software, Smarthood bridges critical gaps in workflow, compliance, and traceability—empowering facilities to enhance safety, efficiency, and data transparency like never before. Read more here!

Sponsorships Available: Bay Area Science Festival
By CLS Member: UCSF
06/04/25 – The Bay Area Science Festival, Northern California’s largest free celebration of science, returns Saturday, October 25, 2025 at UCSF’s Mission Bay Campus. Join us as a sponsor! Learn more here!

Germfree Expands Market Reach and Facility Solutions with Arcoplast Acquisition
By CLS Member: Germfree
05/30/25 – Germfree is pleased to announce the acquisition of Arcoplast, a strategic move that strengthens its turnkey cleanroom facility solutions and broadens its market reach. This partnership enhances Germfree’s capabilities by integrating superior architectural finishes, allowing the company to deliver even more comprehensive and high-quality environments for pharmaceutical, biotech, and biocontainment. Read more here!

Wacker Biotech and Expression Manufacturing announce strategic partnership to accelerate development of lentiviral-based gene and cell therapies
By CLS Member: Wacker Biotech
05/28/25 – Wacker Biotech US Inc., a wholly owned subsidiary of Wacker Chemie AG specializing in plasmid DNA (pDNA) production, and Expression Manufacturing, a leader in viral vector technology, have entered into a strategic collaboration. Its goal is to advance the development and manufacturing of lentiviral-based gene and cell therapies. Read more here!

BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology
By CLS Member: BeOne Medicines
05/27/25 – BeOne Medicines Ltd., a global oncology company formerly known as BeiGene, Ltd., today announced its new name and redomiciliation to Switzerland are officially in effect, marking a significant milestone in the Company’s evolution. Read more here!

Sapio Sciences Appoints Gordon McCall as Chief Operating Officer to Drive Global Operational Excellence
By CLS Member: Sapio Sciences
05/27/25 – Sapio Sciences, the science-aware™ lab informatics platform, today announced the promotion of Gordon McCall to Chief Operating Officer (COO). McCall has served as the company’s Chief Financial Officer (CFO) since 2022 and brings a proven track record of leadership, strategic execution, and operational acumen. Read more here!

Optimize Your Supply Chain with the 24 Essentials – Watch the Webinar Recording
By CLS Member: QAD
05/19/25 – Missed the live session? No problem — now you can watch it on demand!
Discover how Moog Medical partnered with QAD to turn their supply chain into a competitive advantage by focusing on just 3 of the 24 Essential Supply Chain Processes. Watch the webinar here!

Sapio Sciences Introduces Biorepository Management Solution in Sapio Release 25.4
By CLS Member: Sapio Sciences
04/30/25 – Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen managementpport our community with powerful, accessible, and expert-driven mass spectrometry analysis. Read more here!

MBC’s Advanced Mass Spectrometry Center – In Partnership with Agilent
By CLS Members: MBC BioLabs and Agilent
04/29/25 – We’re proud to introduce the Advanced Mass Spectrometry Center at our 1030 Brittan location—an in-house resource built to support our community with powerful, accessible, and expert-driven mass spectrometry analysis. Read more here!

FOR LEASE | INCUBATOR LAB & OFFICE SPACE | 999 BAKER WAY | SAN MATEO, CA
By CLS Member: Kidder Matthews
04/23/25 – An exceptional opportunity is now available at the Incubator @ Baker, located on the 4th floor of 999 Baker Way in San Mateo. This flexible, amenity-rich facility offers fully furnished lab and office suites ranging from ±100 SF to ±15,095 SF, with options starting at $2,000/month for individual lab benches and $25,000/month for private lab suites. Read more here!

eBook – Hiring in Life Sciences: Finding Skills and Building a Team in a Rapid-Growth Industry
By CLS Member: Yoh Services, LLC
04/21/25 – For more than a decade, the Life Sciences industry has grown rapidly, driven by major tech advancements and increased investment in R&D to tackle pressing medical and biological challenges. Check out this eBook to explore key hiring trends and considerations for building a team with the right skills to meet your Life Sciences goals. Read more here!

Hiring for CDMOs/CMOs in California: Finding the Right Talent in a Changing Market
By CLS Member: Stephanie Kashey, Sr. Business Development Manager, Yoh Services, LLC
04/21/25 – As California’s life sciences sector regains momentum, CDMOs and CMOs are ramping up hiring—but finding specialized talent quickly remains a challenge. This blog explores how targeted hiring strategies, temp-to-perm flexibility, and specialized staffing partners like Yoh can help biopharma companies meet tight client deadlines without the risk of overhiring. Read more here!

Biointron Insights: Antibody Industry Report (Q1 2025 Insights, Trends & Analysis)
By CLS Member: Biointron
04/09/25 – Biointron’s Q1 2025 antibody report aims to explore the events and trends of the biopharmaceutical industry in 2025 (January, February, March). This quarter, 6 novel monoclonal antibody drugs have been approved by at least one regulatory agency around the world: three from China, two from the EU, and one from Australia. Read more here!

Wacker Biotech Announces Strategic Collaboration with RNAV8 Bio to Enhance mRNA Therapeutics Development
By CLS Member: Wacker Biotech
04/03/25 – Wacker Biotech, a leading contract development and manufacturing organization (CDMO) wholly owned by Wacker Chemie AG, today announced a strategic collaboration with RNAV8 Bio, a Boston-based pioneer in mRNA engineering. The collaboration is aimed at progressing the development and production of mRNA-based advanced therapies for the biopharma industry. Read more here!

Why Sustainable Labs Can’t Wait
By CLS Member: Arcondis
03/27/25 – While global environmental change, including climate change, is now widely recognised, the healthcare sector has only recently begun to fully acknowledge its impact on the environment. The sector is still in the early stages of identifying necessary changes and taking actions to significantly address and reduce its impact. With time running out, the healthcare sector must urgently address sustainability. Read more here!

Pitching Gastroenterology Advancements QuickFire Challenge
By CLS Member: Johnson & Johnson
03/25/25 – We are proud to announce the launch of the Pitching Gastroenterology Advancements #QuickFireChallenge. This is your chance to showcase your ideas with potential to transform the future of gastrointestinal (GI) disease treatment. Innovators worldwide are invited to submit novel approaches to modulating gut barrier function and integrity towards achieving epithelial barrier homeostasis and healing, including novel approaches and targets to prevent or repair epithelial damage, and methods for assessing barrier function/dysfunction. Innovators with the most promising ideas will have an opportunity to showcase their science, either in person or virtually, to a panel of Johnson & Johnson Innovative Medicine Immunology leaders during the 2025 Digestive Disease Week (DDW) Conference in San Diego, CA, May 3-6, 2025. Read more here!

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo
By CLS Member: Sapio Sciences
03/19/25 – Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery. Read more here!

The Top 10 Questions You Should Be Asking Your CPA This Tax Season
By CLS Member: Withum
03/18/25 – Navigating the complex landscape of tax regulations in the life sciences and technology industries requires a knowledgeable CPA and a proactive approach to identifying tax-saving opportunities and ensuring compliance. Read more here!

Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board
By CLS Member: Montara Therapeutics
03/13/25 – Montara Therapeutics, a biotech company pioneering brain-selective therapies for CNS diseases, today announced the closing of a $20 million oversubscribed expansion of its Series Seed financing. The round, which brings Montara’s total seed funding to $28 million, includes increased participation from all existing investors. Read more here!

Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem
By CLS Member: Regeneron Pharmaceuticals
03/11/25 – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Matteo Paz,18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s oldest and most prestigious science and math competition for high school seniors. Read more here!
Submit Your Content
CLS members can submit articles, press releases, whitepapers, and/or blogs to be featured on the ‘Member Voice’ section of our website.
Learn more about all of the ways CLS elevates the voice of our members. Not yet a member? Join CLS today to start taking advantage of this exclusive member benefit.
To be eligible, organizations must meet the following criteria:
- Be an active CLS member.
- Content should complement CLS’s mission of empowering our life sciences community to deliver innovative solutions for healthier lives.
- Highlight your current organizational initiatives, press releases, patient stories, recent news articles, challenges and opportunities for our industry, areas of focus, major milestones, success stories, etc.
- Include a high-resolution .png or .jpg logo
- No more than two organizational submissions per month
*Spotlight submissions will be selected at the discretion of CLS and featured in our monthly newsletter.
Content Archive
- 02/26/25 – Sanker IP – ACI Life Sciences AI Summit in New York City
- 02/24/25 – Medtronic – Medtronic earns U.S. FDA approval for the world’s first Adaptive deep brain stimulation system for people with Parkinson’s
- 02/20/25 – MaxCyte – MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
- 02/18/25 – Sapio Sciences – Sapio Sciences Expands Leadership Team to Drive Growth
- 02/11/25 – IFLI – A Transformative Year in Advancing Patient Outcomes and Research Breakthroughs
- 02/06/25 – Icarus Therapeutics – The Evolution of Decentralized Clinical Trials: Blending Innovation and Regulation in the Digital Age
- 02/06/25 – APD Ltd. – Navigating CMC Pitfalls
- 02/04/25 – Sapio Sciences – Sapio Sciences Selected by LabConnect to Transform Laboratory Operations
- 02/03/25 – MaxCyte – MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments
- 01/29/25 – Sloane Partners – Erik Fink Named co-CEO at Slone Partners
- 01/29/25 – Kelly Science & Clinical – 2025 Hiring Outlook and Trend Report
- 01/28/25 – Sapio Sciences – Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure
- 01/14/25 – Sapio Sciences – Sapio Sciences Achieves Hébergeur de Données de Santé (HDS) Certification
- 01/14/25 – Sapio Sciences – Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology
- 01/13/25 – Flannery Sales Systems – Proactive New Business Development: Fill The Pipeline!
- 01/07/25 – Guardant Health – Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
- 12/12/24 – Withum – Are Patent Litigation Expenses Relating to ANDA Tax Deductible?
- 12/09/24 – Phastar – Phastar Scoops Prestigious 2024 Scrip Award
- 12/03/24 – Sapio Sciences – evitria Partners with Sapio Sciences to Streamline Antibody Workflow Management and Reporting
- 11/26/24 – Tangibly – Announcing QuickStart, the Key Building Blocks to Launch a Trade Secret Program
- 11/25/24 – IRBM – IRBM Group Achieves Gold Rating for Sustainability from EcoVadis
- 11/19/24 – Gladstone Institutes – Gladstone President Deepak Srivastava Named 2024 Distinguished Citizen by Commonwealth Club World Affairs
- 11/18/24 – Sapio Sciences – Sapio Sciences Collaborates with Waters Corporation to Improve Efficiency of Laboratory Operations
- 11/07/24 – Flannery Sales Systems – How to Establish Value in Life Sciences Sales
- 11/05/24 – Otsuka – Family caregivers perform six-figure work for free
- 10/31/24 – Ansell – Exclusive Educational Opportunity for Members
- 10/29/24 – APC Ltd – De-Coupling Process Development from Manufacturing
- 10/29/24 – Sapio Sciences – Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
- 10/25/24 – Biointron – Biointron Insights: Antibody Industry Report (Q3 2024 Insights, Trends & Analysis)
- 10/16/24 – Labcon – Labcon Receives My Green lab Award
- 10/15/24 – Sapio Sciences – Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
- 10/10/24 – Expression Systems – Whitepaper from the University of Waterloo, Canada
- 10/10/24 – MaxCyte – MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer